Samatasvir, CAS [[1312547-19-5]]
Artikelnummer:
BYT-ORB1298018
Produktübersicht
Artikelname:
Samatasvir, CAS [[1312547-19-5]]
Artikelnummer:
BYT-ORB1298018
Hersteller Artikelnummer:
orb1298018
Alternativnummer:
BYT-ORB1298018-1, BYT-ORB1298018-1, BYT-ORB1298018-10, BYT-ORB1298018-100, BYT-ORB1298018-25, BYT-ORB1298018-5, BYT-ORB1298018-50
Hersteller:
Biorbyt
Kategorie:
Biochemikalien
Alternative Synonym:
Samatasvir, replication, IDX719, IDX-719, IDX18719, IDX-18719, IDX 18719, IDX 719, Inhibitor, HCV Protease, HCVProtease, HCV, Hepatitis C virus, inhibit, infectious, NS5A, ATOLIHZIXHZSBA-BTSKBWHGSA-N, antiviral agent
Produktbeschreibung
Samatasvir is a pan-genotypic small molecule inhibitor targeting the hepatitis C virus (HCV) non-structural protein 5A (NS5A). It is utilized in antiviral research for studying HCV replication mechanisms and has been evaluated in both in vitro assays and clinical (in vivo) trials for combination therapies.
Produkteigenschaften
Molekulargewicht:
885.06
Reinheit:
98.04% (May vary between batches)
CAS Nummer:
[1312547-19-5]
Formel:
C47H48N8O6S2
Target-Kategorie:
HCV Protease
Anwendungsbeschreibung
Anwendungsbeschreibung:
Solubility: DMSO:50 mg/mL (56.49 mM),10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (2.26 mM)
